Design, synthesis and biological evaluation of novel artesunate-selenylindole hybrids against colorectal cancer
Bioorganic Chemistry · 2026
DOI: 10.1016/j.bioorg.2026.110504 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic Chemistry, 2026. Verfasst von Jianlong Cao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Guangxi Key Laboratory of Drug Discovery and Optimization, Guangxi Engineering Research Center for Pharmaceutical Molecular Screening and Druggabilit…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Indoles, Colorectal Neoplasms, Drug Design. Die Arbeit nennt 51 Literaturangaben. Gefördert von: Natural Science Foundation of Guangxi Province, Scientific Research and Technology Development Program of Guangxi Zhuang Autonomous Region.
Abstract (Originalsprache)
Colorectal cancer (CRC) remains a major global public health threat, creating an urgent demand for novel therapeutic agents. Artesunate (ART), a semisynthetic derivative of artemisinin, has demonstrated anti-colorectal cancer effects, but its moderate antitumor potency (IC50 > 50 μM) severely limits further clinical application. To enhance the activity against colorectal cancer (CRC), we adopted a scaffold hybridization strategy to rationally design and synthesize 22 novel artesunate-selenylindole hybrids. All derivatives were screened for their anti-proliferative activity against four human colorectal cancer cell lines (HT29, HCT116, SW480, SW620) and normal human liver cells (LO2). Most derivatives exhibited superior anti-proliferative activity compared to ART (IC50 > 50 μM), and compound 3e demonstrated significant anti-proliferative activity against HCT-116 cells with an IC50 of 6.0 μM and exhibiting no toxicity toward normal cells. Further cellular assays verified that 3e suppresses colony formation and cell migration of HCT116 in a dose-dependent fashion. Mechanistically, 3e inhibits TrxR activity to trigger intracellular ROS overaccumulation and mitochondrial dysfunction. The accumulated oxidative stress elicits G0/G1 cell-cycle arrest and pronounced mitochondrial-dependent apoptosis, characterized by elevated Bax, cleaved-caspase-3, cleaved-PARP, reduced Bcl-2 and procaspase-3, and the release of cytochrome-c from mitochondria to cytoplasm. In summary, compound 3e displays potent anti-CRC effects through TrxR/ROS-driven oxidative-stress signaling, representing an attractive lead scaffold for anti-CRC drug discovery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangxi Key Laboratory of Drug Discovery and Optimization, Guangxi Engineering Research Center for Pharmaceutical Molecular Screening and Druggability Evaluation, School of Pharmacy, Guilin Medical University, Guilin 54…
- Pharmaceutical Research & Development Department, Guilin Pharmaceutical Co., Ltd., Guilin 541004, Guangxi, China.
Förderung
- Natural Science Foundation of Guangxi Province
- Scientific Research and Technology Development Program of Guangxi Zhuang Autonomous Region
Zitieren
APA
Cao, J., Yuan, G., Li, C., Ren, M., Pang, J., Zhang, Z., Lu, P., Wei, J., Ma, X., Zhang, Y., Chen, Y., & Xu, Y. (2026). Design, synthesis and biological evaluation of novel artesunate-selenylindole hybrids against colorectal cancer. Bioorganic Chemistry. https://doi.org/10.1016/j.bioorg.2026.110504
Vancouver
Cao J, Yuan G, Li C, Ren M, Pang J, Zhang Z, et al. Design, synthesis and biological evaluation of novel artesunate-selenylindole hybrids against colorectal cancer. Bioorganic Chemistry. 2026. doi:10.1016/j.bioorg.2026.110504
BibTeX
@article{Cao2026,
author = {Cao, Jianlong and Yuan, Ge and Li, Changgui and Ren, Meilin and Pang, Jiaxin and Zhang, Zhenyu and Lu, Ping and Wei, Jianhua and Ma, Xianli and Zhang, Ye and Chen, Yanyan and Xu, Yanli},
title = {Design, synthesis and biological evaluation of novel artesunate-selenylindole hybrids against colorectal cancer},
journal = {Bioorganic Chemistry},
year = {2026},
doi = {10.1016/j.bioorg.2026.110504}
}
EUVIMED